Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
Authors
Keywords
-
Journal
CELL CYCLE
Volume 11, Issue 21, Pages 4020-4032
Publisher
Informa UK Limited
Online
2012-10-23
DOI
10.4161/cc.22225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas
- (2015) Daniela Gasparotto et al. Oncotarget
- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 Expression
- (2015) Farhad Vesuna et al. NEOPLASIA
- Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
- (2012) Toni Celià-Terrassa et al. JOURNAL OF CLINICAL INVESTIGATION
- A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity
- (2012) Frances L. Shaw et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Cancer Stem Cell Hypothesis and Trastuzumab in HER2-Negative Tumors
- (2012) R. S. Tuma JNCI-Journal of the National Cancer Institute
- Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ER - breast cancer
- (2012) J. C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapies
- (2011) Cristina Oliveras-Ferraros et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
- (2011) K Pandya et al. BRITISH JOURNAL OF CANCER
- Snail2 is an Essential Mediator of Twist1-Induced Epithelial Mesenchymal Transition and Metastasis
- (2011) E. Casas et al. CANCER RESEARCH
- Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition
- (2011) Ahmed F. Salem et al. CELL CYCLE
- Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions
- (2011) Bolin Liu et al. CELL CYCLE
- E-cadherin, a new mixer in the Yamanaka cocktail
- (2011) William E Lowry EMBO REPORTS
- E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming
- (2011) Torben Redmer et al. EMBO REPORTS
- HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells
- (2011) Wei Bao et al. GASTROENTEROLOGY
- Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype
- (2011) J Jiang et al. ONCOGENE
- Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations
- (2011) S Floor et al. ONCOGENE
- Dynamic emergence of the mesenchymal CD44posCD24neg/low phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin)
- (2010) Cristina Oliveras-Ferraros et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
- (2010) Poornima Bhat-Nakshatri et al. BMC CANCER
- The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
- (2010) Alejandro Vazquez-Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Molecular biology of breast cancer stem cells: Potential clinical applications
- (2010) Nam P. Nguyen et al. CANCER TREATMENT REVIEWS
- Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis
- (2010) Sílvia Cufí et al. CELL CYCLE
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- When Fibroblasts MET iPSCs
- (2010) Jose M. Polo et al. Cell Stem Cell
- A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts
- (2010) Ronghui Li et al. Cell Stem Cell
- Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming
- (2010) Payman Samavarchi-Tehrani et al. Cell Stem Cell
- Defining the E-Cadherin Repressor Interactome in Epithelial-Mesenchymal Transition: The PMC42 Model as a Case Study
- (2010) Honor J. Hugo et al. CELLS TISSUES ORGANS
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Targeting Breast Cancer Stem Cells
- (2010) Suling Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
- (2010) Tony Blick et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
- (2010) Douglas S. Micalizzi et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- 1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
- (2009) D. Lesniak et al. CANCER RESEARCH
- Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
- (2009) A. Magnifico et al. CLINICAL CANCER RESEARCH
- Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers
- (2009) Catarina Castro Alves Frontiers in Bioscience-Landmark
- Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2009) Neil L. Spector et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework
- (2009) Bisrat G. Debeb et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Stemming Resistance to HER-2 Targeted Therapy
- (2009) Philippe L. Bedard et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Molecular predictors of response to trastuzumab and lapatinib in breast cancer
- (2009) Francisco J. Esteva et al. Nature Reviews Clinical Oncology
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44
- (2008) Zsuzsanna Pályi-Krekk et al. CANCER LETTERS
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Epithelial mesenchymal transition traits in human breast cancer cell lines
- (2008) T. Blick et al. CLINICAL & EXPERIMENTAL METASTASIS
- Estrogen-mediated downregulation of CD24 in breast cancer cells
- (2008) Benny Abraham Kaipparettu et al. INTERNATIONAL JOURNAL OF CANCER
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
- (2008) Madhuri Kakarala et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
- (2008) C Osipo et al. ONCOGENE
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
- (2008) Anne-Pierre Morel et al. PLoS One
- The basal-like breast carcinoma phenotype is regulated bySLUGgene expression
- (2007) G Storci et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started